| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.0094 | 1 |